UK markets open in 1 hour 49 minutes

Dr. Reddy's Laboratories Limited (DRREDDY.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
6,242.10+37.80 (+0.61%)
As of 10:41AM IST. Market open.
Currency in INR

Valuation measures4

Market cap (intra-day) 1.03T
Enterprise value 980.82B
Trailing P/E 19.80
Forward P/E 20.33
PEG ratio (5-yr expected) 4.91
Price/sales (ttm)3.81
Price/book (mrq)3.86
Enterprise value/revenue 3.62
Enterprise value/EBITDA 11.55

Trading information

Stock price history

Beta (5Y monthly) 0.34
52-week change 324.89%
S&P500 52-week change 323.57%
52-week high 36,505.90
52-week low 34,384.05
50-day moving average 36,209.07
200-day moving average 35,826.01

Share statistics

Avg vol (3-month) 3361.05k
Avg vol (10-day) 3428.63k
Shares outstanding 5166.53M
Implied shares outstanding 6166.55M
Float 8119.82M
% held by insiders 18.30%
% held by institutions 167.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 440
Forward annual dividend yield 40.64%
Trailing annual dividend rate 340.00
Trailing annual dividend yield 30.64%
5-year average dividend yield 40.62
Payout ratio 412.77%
Dividend date 3N/A
Ex-dividend date 411 Jul 2023
Last split factor 22:1
Last split date 328 Aug 2006

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 19.24%
Operating margin (ttm)24.74%

Management effectiveness

Return on assets (ttm)12.38%
Return on equity (ttm)21.39%

Income statement

Revenue (ttm)271.3B
Revenue per share (ttm)1,631.51
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)N/A
EBITDA 80.98B
Net income avi to common (ttm)52.21B
Diluted EPS (ttm)313.32
Quarterly earnings growth (yoy)10.60%

Balance sheet

Total cash (mrq)72.55B
Total cash per share (mrq)435.7
Total debt (mrq)19.85B
Total debt/equity (mrq)7.41%
Current ratio (mrq)2.55
Book value per share (mrq)1,608.58

Cash flow statement

Operating cash flow (ttm)53.59B
Levered free cash flow (ttm)23.21B